At baseline , of @ patients , @ % had levels of HCV RNA @,@ IU/mL , @ % had fibrosis ( F@-F@ ) , @ % had cirrhosis ( F@ ) , @ % were infected with HCV genotype @a , and @ % had the non-CC IL@B genotype .